{
  "retracted": false,
  "timestamp": 1598572800000,
  "updates": [
    {
      "timestamp": 1591630854619,
      "identifier": {
        "doi": "10.1016/j.canlet.2020.05.010"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1016/j.canlet.2014.05.012"
  },
  "journal": "Cancer Letters",
  "publisher": "Elsevier BV",
  "title": "Corrigendum to “SOMCL-863, a novel, selective and orally bioavailable small-molecule c-Met inhibitor, exhibits antitumor activity both in vitro and in vivo” [Cancer Lett. 351 (2014) 143–50]"
}
